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Abstract Base excision repair (BER) of DNA corrects a
number of spontaneous and environmentally induced genotoxic
or miscoding base lesions in a process initiated by DNA
glycosylases. An AP endonuclease cleaves at the 5P side of the
abasic site and the repair process is subsequently completed via
either short patch repair or long patch repair, which largely
require different proteins. As one example, the UNG gene
encodes both nuclear (UNG2) and mitochondrial (UNG1) uracil
DNA glycosylase and prevents accumulation of uracil in the
genome. BER is likely to have a major role in preserving the
integrity of DNA during evolution and may prevent cancer. ß
2000 Federation of European Biochemical Societies. Published
by Elsevier Science B.V. All rights reserved.
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1. Introduction
The integrity of DNA depends upon several processes that
in part are integrated. These include DNA damage recogni-
tion and repair, replication, transcription and cell cycle regu-
lation. In addition, programmed cell death (apoptosis) con-
tributes to the genetic integrity by removing genetically altered
cells. Most damaged or inappropriate bases in DNA are re-
moved by excision repair, while a minority are repaired by
direct damage reversal [1]. In base excision repair (BER) the
damaged nucleotide is removed, the resulting single-stranded
area is ¢lled in by DNA synthesis, and the new segment li-
gated to the preexisting strand downstream of the damaged
area.
Small base alterations that do not distort the DNA helix
(e.g. uracil and 3-methyladenine (3-meA)) are generally re-
paired by BER in a multistep process initiated by a dam-
age-speci¢c DNA glycosylase which releases the damaged
base. This leaves an abasic site that is subsequently processed
further in a multistep pathway that restores the correct DNA
sequence [2,3]. Covalent DNA alterations that also distort the
DNA helix (e.g. pyrimidine dimers and benzpyrene adducts)
are repaired by nucleotide excision repair (NER) which is
initiated by an invariant damage-recognising multiprotein
complex. In this case, two di¡erent endonucleases (XPF-
ERCC1 and XPG) associated with the complex cleave 5P
and 3P of the damage, thus releasing the damaged base as
part of an oligonucleotide [1]. The mismatch repair (MMR)
system constitutes the third major excision repair pathway.
This system recognises single mispairs and mismatches involv-
ing several bases. MMR has attracted wide attention because
defective MMR genes are responsible for the vast majority of
cases of hereditary non-polyposis colon cancer [4].
2. Mammalian DNA glycosylases and BER
BER was discovered by Tomas Lindahl in 1974 as the result
of a search for an enzymatic activity that would act on de-
aminated cytosine [5]. The enzyme he discovered, uracil DNA
glycosylase, represented a new type of enzyme that released
the damaged base. Subsequently a number of other DNA
glycosylases have been reported (Table 1). These generally
remove bases that cause minor structural changes in DNA.
The damage recognised is most frequently the result of the
inherent instability of DNA. This includes deamination of
cytosine to uracil, alkylation caused by normal cellular metab-
olites such as S-adenosylmethionine, (e.g. 3-meA), oxidative
damage caused by reactive oxygen species from oxidative me-
tabolism (e.g. 8-oxoG and thymine glycol), and errors in
DNA replication (misincorporation of dUTP or 8-oxo-
dGTP). Many of these lesions are also caused by environ-
mental agents, such as tobacco-speci¢c nitrosamines that al-
kylate DNA, and ionising radiation that generates reactive
oxygen species. All mammalian DNA glycosylases have N-
terminal extensions that are not present in the bacterial coun-
terparts. When known, these sequences have important func-
tions in targeting enzymes to nuclei or mitochondria and in
interactions with other proteins that may have a role in BER
[2,6]. DNA glycosylases are generally small, monomeric pro-
teins that cleave the N^C1P glycosylic bond between the base
and deoxyribose, thus releasing the damaged base and leaving
an abasic site that is cytotoxic and mutagenic and must be
further processed. Removal of the damaged base is the only
catalytic function of monofunctional DNA glycosylases, such
as uracil DNA glycosylases (UNG), the mismatch-speci¢c
thymine/uracil DNA glycosylase (TDG) and the methylpurine
DNA glycosylases (MPG, also called ANPG or AAG).
Whereas UNG and TDG have narrow substrate speci¢cities,
MPG removes a large array of damaged bases which have a
weakened glycosylic bond as their only common feature [2].
Several DNA glycosylases have associated lyase activities that
cleave at the 3P side of the abasic site. Prototype examples of
such enzymes are enzymes that remove oxidised purines such
as 8-oxoG DNA glycosylase (OGG1) and the human Endo
III homologue hNTH1 that removes oxidised pyrimidines.
After removal of the damaged base by a DNA glycosylase
and incision by AP endonuclease, BER may proceed by ‘short
patch repair’ or by ‘long patch repair’ (Fig. 1). In short patch
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repair the repair gap is only one nucleotide, while in long
patch repair the gap is 2^8 nucleotides in size [7,8]. The
type of DNA glycosylase is one determinant for selection of
the BER pathway. Thus, in vitro repair in HeLa cell extracts
revealed that removal of two substrates by the monofunction-
al MPG/ANPG takes place by via both short and long patch
repair, while repair of 8-oxoG initiated by the bifunctional
OGG1 glycosylase/lyase takes place mainly via short patch
repair [9]. It is also possible that the cell cycle stage is a
determinant. Thus, removal of misincorporated uracil takes
place in replication foci which contain all factors required
for long patch repair, but not DNA polymerase L, the pre-
ferred polymerase in short patch repair [6]. However, DNA
polymerase L has been shown to stimulate long patch repair
for uracil removal in cell extracts where it displaces the dam-
aged strand and co-operates with ‘£ap endonuclease’ FEN1 in
excision of the incised damaged strand [10]. If this mechanism
operates in vivo it must presumably take place outside repli-
cation foci.
Table 1
Mammalian DNA glycosylases [1^3]
Namea Size
(aa)
Lyase
activity
Cellular
localisation
Chromosome
localisation
Known substratesb
hUNG1 304 No Mitochondria 12q24.1 ssUsU:GsU:A, 5-FU (poor: 5-hydroxyU, isodialuric acid,
alloxan)
hUNG2 313 No Nuclei 12q24.1 ssUsU:GsU:A, 5-FU (poor: 5-hydroxyU, isodialuric acid,
alloxan)
mUNG1 295 No Mitochondria ^ U, 5-FU
mUNG2 306 No Nuclei ^ U, 5-FU
hSMUG1 270 No 12q13.1^q14 ssUsU:A, U:G
hTDG 410 No Nuclei 12q24.1 U:Gs OC:GsT:G
hMBD4 580 ? ^ 3q21 U or T in U/TpG:5-meCpG
hUDG2 327 No ^ 5 U:A
hMPG 293 No ^ 16p (telomere) 3-mA, 7-mA, 3-mG,7-mG, 8-oxoG, hypoxanthine, OA, OG
mMPG ^ No ^ ^ 3-mA, 7-mA, 3-mG
hOGG1c 345 Yes Nuclei (1a) 3p25 Me-fapyG:CEfapyG:Cs 8-oxoG:CE8-oxoG:T
424 Yes Mitochondria (2a)
mOGG1 345 Yes ^ 8-oxoG:CE8-oxoG:Ts 8-oxoG:G
hMYHd 521 Yes? Mitochondria 1p32.1^p34.3 A:G, A:8-oxoGEC:A, 2-OH-A
535 Yes? Nuclei 1p32.1^p34.3 A:G, A:8-oxoGEC:A, 2-OH-A
hNTH1 312(304) Yes Nuclei (+mitoch?) 16p13.2^13.13 T/C-glycol, dihydrouracil, fapy,
mNTH1 300 Yes ^ 17A3 T-glycol, urea
ah = human, m = mouse.
bIn mismatches, the target base is at the left.
cThirteen alternative OGG1 transcripts have been demonstrated, of which only 1a encodes a nuclear localisation signal.
dTen alternative hMYH transcripts have been demonstrated.
Fig. 1. Alternative BER pathways. A, B: Short-patch BER initiated
by bifunctional and monofunctional glycosylases, respectively. Un-
modi¢ed AP sites result in a one-nucleotide repair patch generated
by a common ligation step. C: Processing of reduced or oxidised
AP sites proceeds via the PCNA-dependent pathway, and involves
cleavage of a 2^8-nucleotide ‘£ap’ by FEN-1.
Fig. 2. Generation of nuclear (UNG2) and mitochondrial (UNG1)
forms of UDG. A: The 13.5-kb UNG gene consists of seven exons
and uses alternative promoters (A and B) and alternative splicing to
generate UNG2 and UNG1 respectively. B: Structures of promoters
A and B, indicating positive and negative regulatory elements. C:
Intracellular transport of UNG1 (mitochondria) and UNG2 (nuclei)
is determined by alternative N-terminal presequences. D: Amino
acid sequences of unique and common regions in the UNG1 and
UNG2 N-terminal domains. Residues 1^29 in UNG1 are cleaved
o¡ during mitochondrial import. Binding motifs in UNG2 to
PCNA and RPA are indicated. Potential Ser/Thr phosphorylation
sites in UNG2 are shown by asterisks. E: Amino acids in the hu-
man UNG2 PCNA binding region are conserved in yeast and
mouse, and are also found in p21.
C
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3. Mammalian 3-meA DNA glycosylase (MPG, AAG, ANPG)
MPG has a wide substrate speci¢city that includes several
alkylated purines, 1-N6-ethenoadenine and hypoxanthine. It
shares this property with the bacterial enzyme AlkA although
they are not related in their amino acid sequences [2]. The 3D
structure of MPG revealed intercalation into the minor
groove of DNA, £ipping of the damaged nucleotide into the
electron-rich active site, where a bound water molecule is
poised for nucleophilic attack [11]. Knockout mice de¢cient
in MPG have demonstrated that the enzyme is not essential
for development or survival, and somewhat surprisingly,
spontaneous mutation frequencies were not increased
[12,13]. This indicates that alkylation by endogenous metabo-
lites is probably not a major mutagenic load. MPG-de¢cient
cells are, however, hypersensitive to killing by alkylating
agents [12] and demonstrate a 3^4-fold increased mutation
frequency in the hprt gene after exposure to alkylating agents
[13].
4. Mammalian DNA glycosylases for oxidative lesions
Oxidative stress from normal metabolism or ionising radi-
ation causes oxidative damage to both purines and pyrimi-
dines. 8-oxoG opposite C in DNA results from oxidation of
template Gs. This lesion is removed by OGG1. This relatively
abundant lesion [14] is mutagenic because it may direct incor-
poration of either dCMP or dAMP. This may result in a GC
to TA transversion. However, if template 8-oxoG escapes re-
pair and dAMP is incorporated, hMYH glycosylase, which
speci¢cally removes A opposite 8-oxoG, may serve as a sec-
ondary defence mechanism [2]. This gives the DNA polymer-
ase a second chance to incorporate dCMP, and subsequently
8-oxoG opposite C may be removed by OGG1. Like MPG-
de¢cient mice, knockout mice de¢cient in OGG1 develop nor-
mally and do not have an obvious clinical phenotype,
although they accumulate 8-oxoG in the genome and show
slightly increased spontaneous mutation frequencies [14].
Oxidised pyrimidines, e.g. thymine glycol and cytosine gly-
col, are removed by hNTH1, a human homologue of Esche-
richia coli Endo III encoded by the nth gene. It removes at
least ¢ve di¡erent oxidised pyrimidines [15]. This enzyme has
little activity alone, but is stimulated several-fold by XPG, an
endonuclease that has an important function in NER. In BER
XPG has a di¡erent role and apparently aids hNTH1 binding
to target DNA [16,17]. Thus, XPG has a veri¢ed role in both
BER and NER.
5. DNA glycosylases that remove uracil from DNA
Enzymes that remove uracil from DNA are collectively
called uracil DNA glycosylase (UDG). Deamination of cyto-
sine creates mutagenic U:G mispairs at a frequency of 100^
500 events per cell per day. In addition dUTP, a normal
intermediate present in low concentrations in the cell, may
be incorporated opposite template adenine during replication
[2,18]. While UDG encoded by the UNG gene encodes the
majority of the total UDG activity [19], several other UDG
activities may be important as backup enzymes, or they may
serve specialised functions that are not yet fully understood.
These enzymes include the T(U):G mismatch DNA glycosy-
lase, TDG [20], SMUG1 [21], MBD4 [22] and a cyclin-like
enzyme [23]. Among these uracil-releasing activities only the
UNG proteins and TDG have been characterised in more
detail so far. TDG requires a T(U):G mismatch, and in con-
trast to UNG it is essentially inactive with U:A pairs and
single-stranded DNA. It also removes 3-N(4)-ethenocytosine
opposite G [24]. The structure of MUG, the bacterial homo-
logue of TDG, in complex with target DNA has been solved.
MUG/TDG enzymes are structurally related to the common
catalytic core domain of UNG proteins, but have a very dif-
ferent mechanism for substrate recognition [25]. TDG is also
larger than UNG because it requires double-stranded DNA
and interacts with both the damage-containing strand and the
complementary strand. Human TDG and the homologous
enzyme MUG have very low catalytic rates compared with
the UNG proteins.
The UNG gene contains seven exons, is approximately 13.5
kb and is located in chromosome 12q24.1 [26]. It contains two
di¡erentially expressed TATA-less promoters [27]. Using the
two promoters and alternative splicing, the UNG gene encodes
both the mitochondrial (UNG1) and nuclear (UNG2) forms
of the major human UDG (Fig. 2). Unique N-terminal se-
quences in UNG1 and UNG2 are essential for correct sub-
cellular targeting [28]. The mitochondrial preprotein UNG1 of
304 residues is processed to mature mitochondrial forms that
are 29 and 75/77 amino acids shorter [29]. mRNA for UNG2
encodes a protein of 313 amino acids. The 3D structure of the
common catalytic domain has identi¢ed a positively charged
DNA binding groove and a tight ¢tting catalytic pocket tail-
ored for binding of £ipped-out uracil and exclusion of normal
pyrimidines in DNA. The enzyme-assisted £ipping and release
of uracil have revealed a very complex mechanism for posi-
tioning of uracil and catalysis. This involves the formation of
a destabilised uracil oxyanion intermediate, attack on the gly-
cosyl bond by activated water nucleophile and strain on the
glycosyl bond by conformational changes at the enzyme^
DNA interface [30^33]. The N-terminal amino acids in
UNG2 that are not required for catalytic activity are essential
for complete nuclear translocation and for interaction with
replication protein A (RPA) and proliferating cell nuclear
antigen (PCNA). Furthermore, a large fraction of UNG2
co-locates with RPA and PCNA in replication foci and
UNG2 is important for rapid removal of dUMP residues in-
corporated during DNA replication. This suggests a distinct
function for this protein in immediate postreplicative removal
of misincorporated uracil in DNA. Knockout mice de¢cient in
the murine Ung gene develop normally, have no obvious phe-
notype after 18 months and have a less than twofold increase
in spontaneous mutation frequencies. However, nuclei from
Ung3/3 cells show a strong de¢ciency in removal of misin-
corporated uracils and have a steady-state level of approxi-
mately 2000 uracil residues per cell [34].
DNA glycosylases create mutagenic and cytotoxic abasic
sites. Interestingly, dissociation of UNG from the abasic site
is a rate-limiting step in catalysis, which is stimulated by
HAP1/APE1, the major AP endonuclease [29,32]. This is
also the case for TDG [35]. This indicates that DNA glyco-
sylases may remain attached to the abasic site until the next
player, HAP1, is recruited. Furthermore, HAP1 interacts with
DNA polymerase L that comes next. In turn, DNA polymer-
ase L interacts with XRCC1, a sca¡old protein, which inter-
acts with the last player in short patch repair, DNA ligase III
[1^3]. Thus, BER is a concerted action where the successive
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players interact functionally and/or by protein^protein inter-
actions.
6. Concluding remarks
BER mechanisms are highly conserved in evolution and
apparently an ancient mechanism of defence that counteracts
spontaneous decay of DNA [36]. In addition, BER protects
the genome from chemical and physical threats from the en-
vironment. Apparently, absence of each of the DNA glycosy-
lases separately results in small or moderate changes in spon-
taneous mutation frequencies, and no obvious immediate
e¡ects at the individual level. It is likely that DNA glycosy-
lases have a major role in protecting the long-term integrity of
the genome.
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